课题基金 / 基金详情

Planning an MD-MSc combined degree program focused on translational research to build the next generation of physician-scientist in Peru

Planning an MD-MSc combined degree program focused on translational research to build the next generation of physician-scientist in Peru
规划一个医学博士-理学硕士联合学位课程,重点关注转化研究,以培养秘鲁下一代医师科学家
批准号:
10055600
负责人:
Martin Montes
金额:
$10.8万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-30 至 2022-03-31

项目摘要

项目成果

Martin Montes的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 减轻被忽视的热带病(NTD)的重大负担需要医生-- 科学家和他们的医学突破。美国国立卫生研究院警告说,有必要刺激和保护 职业生涯变得如此渺茫。有才华的医学实习生更有可能取得成功 很早就从事了这样的职业。 考虑到这一原则,佩鲁亚纳·卡耶塔诺·赫雷迪亚大学医学院 (UPCH)与亚历山大·冯·洪堡热带医学研究所(IMTAvH)合作, 为二年级医学生的课程开发了一门入门研究课程 (自2015年开始实施,得到5D43TW009763的支持)。光明二年级和三年级医疗 寻找实际实验室研究机会的学生已经开始了由 蒙特斯博士,首席调查员,以及同事们。新兴的合格本科生群体 致力于医学研究、沿途的导师文化和训练有素的临界人群 职业生涯中期和早期的医生-科学家,决定了UPCH独特的、极其积极的时机 以促进内科科学家职业生涯的组织发展。 加强与德克萨斯州休斯顿贝勒医学院的合作伙伴关系,UPCH的目标是 利用这一前景看好的背景建立第一个生物医学双学位课程 秘鲁,其主要研究重点将是被忽视的热带和艾滋病的免疫机制 肠道疾病。我们设想的全球传染病培训计划(D43)将提供 优秀医学生的临床前培训。为了完善最终的D43,这两个- 年度计划资助的目的是:1)发展理科硕士的课程设计;2)在两个地方发表演讲 学术机构为医学博士提供双重评审要求的可行性- MSC联合计划;3)开发MD/MSC教师的入职计划,刺激良好 针对非常年轻的实习生的指导做法;4)试点实施理科硕士课程组成部分; 5)分析优化受训人员留用和向科学独立性过渡的战略, 秘鲁利益攸关方的参与。 在这一规划过程完成后,我们将处于特殊的地位,可以开发和 实施强大且极具竞争力的D43应用程序,这将成为一项能力建设 秘鲁医生-科学家的里程碑。作为前FIC实习生回到悉尼大学工作了15年 以前,我们渴望为大幅丰富我们光明的研究环境做出贡献 正在培训的本科生内科科学家。
英文摘要
ABSTRACT Reduction of the significant burden of neglected tropical diseases (NTD) calls for physician- scientists and their medical breakthroughs. NIH has alerted about the need to stimulate and protect such dwindling careers. Success is significantly more likely among talented medical trainees who are early engaged in such careers. Considering this principle, the School of Medicine at Universidad Peruana Cayetano Heredia (UPCH), in collaboration with the Institute of Tropical Medicine Alexander von Humboldt (IMTAvH), developed an Introductory Research Course for the curricula of second year medical students (implemented since 2015 with support from 5D43TW009763). Bright 2nd and 3rd year medical students searching for actual lab research opportunities have started research careers mentored by Dr. Montes, Principal Investigator, and colleagues. The emerging pool of qualified undergraduates committed to medical research, along the mentoring culture and the critical mass of highly trained mid- and early career physician-scientists, determines a unique, extremely positive timing at UPCH for an organizational boost of physician scientists’ careers. Reinforcing the partnership with Baylor College of Medicine in Houston, Texas, UPCH aims to leverage on this promising context to establish the first biomedical sciences dual-degree program in Peru, whose main research focus would be immunological mechanisms of neglected tropical and enteric diseases. Our envisioned Global Infectious Diseases Training Program (D43) will be offered to outstanding medical students during their pre-clinical training. To refine the final D43, this two- year planning grant aims to: 1) develop the curricular design of the MSc; 2) address in both academic institutions the feasibility of accommodating dual accreditation requirements for an MD- MSc combined program; 3) develop the induction program for MD/MSc faculty, stimulating good mentoring practices towards very young trainees; 4) pilot implement the MSc curricular components; 5) analyze strategies to optimize trainees’ retention and transition into scientific independence, with involvement of Peruvian stakeholders. After completion of this planning process, we will be in an exceptional position to develop and implement a robust and highly competitive D43 application that will become a capacity building milestone of Peruvian Physician-Scientists. As former FIC trainees who returned to UPCH 15 years ago, we are eager to contribute to substantially enrich the research environment of our bright undergraduate physician scientists in training.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Planning an MD-MSc combined degree program focused on translational research to build the next generation of physician-scientist in Peru
The effect of Strongyloides stercoralis on HTLV-1 disease progression
IMMUNOREGULATION IN HUMAN STRONGYLOIDIASIS
IMMUNOREGULATION IN HUMAN STRONGYLOIDIASIS
海外基金